Prelude Therapeutics

Prelude Therapeutics is a clinical-stage biopharmaceutical company based in Wilmington, Delaware. The company is designing and developing a pipeline of novel, small molecule therapies that target key drivers of cancer cell growth and resistance. Prelude's scientific approach focuses on precision oncology, aiming to translate its discoveries into potential treatments that offer hope to patients with cancer.